Orange Book product · Generic (ANDA)
METHENAMINE HIPPURATE
METHENAMINE HIPPURATE
At a glance
Dec 01, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 01, 2023
2 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
METHENAMINE HIPPURATE
Strength
1GM
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 217675
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHENAMINE HIPPURATE
- —HIPREXBrand (NDA)
NDA 017681 · ESJAY PHARMA
- —UREXBrand (NDA)
NDA 016151 · QUAGEN
- 2025METHENAMINE HIPPURATEGeneric (ANDA)
ANDA 219661 · ZYDUS LIFESCIENCES
- 2020METHENAMINE HIPPURATEGeneric (ANDA)
ANDA 210068 · INGENUS PHARMS LLC
- 2019METHENAMINE HIPPURATEGeneric (ANDA)
ANDA 212172 · MICRO LABS
- 2016METHENAMINE HIPPURATEGeneric (ANDA)
ANDA 205661 · AUROBINDO PHARMA LTD
- 2003METHENAMINE HIPPURATEGeneric (ANDA)
ANDA 076411 · IMPAX LABS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
